These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3960400)

  • 1. Estradiol can suppress haloperidol-induced supersensitivity in dyskinetic monkeys.
    Bédard PJ; Boucher R
    Neurosci Lett; 1986 Feb; 64(2):206-10. PubMed ID: 3960400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar effect of estradiol and haloperidol on experimental tardive dyskinesia in monkeys.
    Bédard PJ; Boucher R; Daigle M; Di Paolo T
    Psychoneuroendocrinology; 1984; 9(4):375-9. PubMed ID: 6514933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen in experimental tardive dyskinesia.
    Gordon JH; Borison RL; Diamond BI
    Neurology; 1980 May; 30(5):551-4. PubMed ID: 7189262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
    Gordon JH; Diamond BI
    Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic effect of estradiol and domperidone on lingual dyskinesia in monkeys.
    Bédard P; Boucher R; Di Paolo T; Labrie F
    Exp Neurol; 1983 Oct; 82(1):172-82. PubMed ID: 6628606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new animal model of dopamine supersensitivity using s.c. implantation of haloperidol releasing polymers.
    Köhler U; Schröder H; Augustin W; Sabel BA
    Neurosci Lett; 1994 Mar; 170(1):99-102. PubMed ID: 8041522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blink rates and receptor supersensitivity.
    Karson CN; Staub RA; Kleinman JE; Wyatt RJ
    Neuropharmacology; 1981 Jan; 20(1):91-3. PubMed ID: 7219685
    [No Abstract]   [Full Text] [Related]  

  • 8. Antagonizing effect of lithium on the development of dopamine supersensitivity in the tuberoinfundibular system.
    Tanimoto K; Maeda K; Chihara K
    Brain Res; 1982 Aug; 245(1):163-6. PubMed ID: 6811103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural effects of dopamine D-1 and D-2 receptor agonists in monkeys previously treated with haloperidol.
    Lublin H; Gerlach J
    Eur J Pharmacol; 1988 Aug; 153(2-3):239-45. PubMed ID: 3263277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diltiazem suppresses apomorphine-induced fighting and pro-aggressive effect of withdrawal from chronic ethanol or haloperidol in rats.
    Pucilowski O; Kostowski W
    Neurosci Lett; 1988 Oct; 93(1):96-100. PubMed ID: 3211374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral tardive dyskinesia in the rat.
    Sundén-Kuronen B; Pohto P; Alanen E
    Acta Odontol Scand; 1983 Dec; 41(6):343-8. PubMed ID: 6581673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The supersensitivity of dopaminergic neurons to apomorphine in rats following chronic haloperidol.
    Vogelsang GD; Piercey MF
    Eur J Pharmacol; 1985 Apr; 110(2):267-9. PubMed ID: 3987817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium effects on haloperidol-induced pre- and postsynaptic dopamine receptor supersensitivity.
    Verimer T; Goodale DB; Long JP; Flynn JR
    J Pharm Pharmacol; 1980 Sep; 32(9):665-6. PubMed ID: 6107377
    [No Abstract]   [Full Text] [Related]  

  • 14. Choline chloride in animal models of tardive dyskinesia.
    Davis KL; Hollister LE; Vento AL; Simonton S
    Life Sci; 1978 May; 22(19):1699-707. PubMed ID: 566830
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of lithium on an animal model of tardive dyskinesia.
    Klawans HL; Weiner WJ; Nausieda PA
    Prog Neuropsychopharmacol; 1977; 1(1-2):53-60. PubMed ID: 569341
    [No Abstract]   [Full Text] [Related]  

  • 17. Supersensitivity to apomorphine and stress two years after chronic methadone treatment.
    Carlson KR
    Neuropharmacology; 1977 Nov; 16(11):795-8. PubMed ID: 413066
    [No Abstract]   [Full Text] [Related]  

  • 18. MK-771 antagonizes the enhanced response to apomorphine in rats treated chronically with haloperidol - implications for tardive dyskinesia.
    Yarbrough GG; Faison EP; Antolik EK
    Neurosci Lett; 1982 Dec; 34(3):321-3. PubMed ID: 6819493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dependence of the effects of tripeptide MIF and lithium chloride on the degree of supersensitivity of dopamine receptors of the brain].
    Bondarenko NA; Val'dman AV
    Biull Eksp Biol Med; 1989 Aug; 108(8):196-9. PubMed ID: 2553154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    Cubeddu LX; Hoffmann IS; James MK; Niedzwiecki DM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):680-5. PubMed ID: 6887008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.